Developing and testing a cost data collection instrument for noncommunicable disease registry planning
- 1 December 2016
- journal article
- Published by Elsevier in Cancer Epidemiology
- Vol. 45, S4-S12
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Resource requirements for cancer registration in areas with limited resources: Analysis of cost data from four low- and middle-income countriesCancer Epidemiology, 2016
- Costs, affordability, and feasibility of an essential package of cancer control interventions in low-income and middle-income countries: key messages from Disease Control Priorities, 3rd editionThe Lancet, 2016
- Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participantsThe Lancet, 2016
- The effect of alternative staff time data collection methods on drug treatment service cost estimatesEvaluation and Program Planning, 2008
- The National Program of Cancer Registries: Explaining State Variations in Average Cost per Case Reported2005
- Variation in Average Costs among Federally Sponsored State-Organized Cancer Detection Programs: Economies of Scale?Medical Decision Making, 2002
- Quality of economic evaluations in health careBMJ, 2002
- Pharmacoeconomics: evaluating the evaluatorsBritish Journal of Clinical Pharmacology, 1997
- Guidelines for Pharmacoeconomic StudiesPharmacoEconomics, 1997
- Standardization of the economic evaluation of health technologies. European developments.1996